Cargando…

Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration

BACKGROUND: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x),...

Descripción completa

Detalles Bibliográficos
Autores principales: Becker, Andreas, Kohlmann, Stephanie, Alexandru, Anca, Jagla, Wolfgang, Canneva, Fabio, Bäuscher, Christoph, Cynis, Holger, Sedlmeier, Reinhard, Graubner, Sigrid, Schilling, Stephan, Demuth, Hans-Ulrich, von Hörsten, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850634/
https://www.ncbi.nlm.nih.gov/pubmed/24083638
http://dx.doi.org/10.1186/1471-2202-14-108
_version_ 1782294132561018880
author Becker, Andreas
Kohlmann, Stephanie
Alexandru, Anca
Jagla, Wolfgang
Canneva, Fabio
Bäuscher, Christoph
Cynis, Holger
Sedlmeier, Reinhard
Graubner, Sigrid
Schilling, Stephan
Demuth, Hans-Ulrich
von Hörsten, Stephan
author_facet Becker, Andreas
Kohlmann, Stephanie
Alexandru, Anca
Jagla, Wolfgang
Canneva, Fabio
Bäuscher, Christoph
Cynis, Holger
Sedlmeier, Reinhard
Graubner, Sigrid
Schilling, Stephan
Demuth, Hans-Ulrich
von Hörsten, Stephan
author_sort Becker, Andreas
collection PubMed
description BACKGROUND: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ. Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic. In addition, it accelerates aggregation of other Aβ species. To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3–42) were generated and comprehensively characterized. To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice. RESULTS: Expression of truncated Aβ(3–42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ. This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation. Neuropathology in ETNA mice was associated with behavioral alterations. In particular, hyperactivity and impaired acoustic sensorimotor gating were detected. Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss. CONCLUSIONS: ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ. Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology. The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models.
format Online
Article
Text
id pubmed-3850634
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38506342013-12-05 Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration Becker, Andreas Kohlmann, Stephanie Alexandru, Anca Jagla, Wolfgang Canneva, Fabio Bäuscher, Christoph Cynis, Holger Sedlmeier, Reinhard Graubner, Sigrid Schilling, Stephan Demuth, Hans-Ulrich von Hörsten, Stephan BMC Neurosci Research Article BACKGROUND: Posttranslational modifications of beta amyloid (Aβ) have been shown to affect its biophysical and neurophysiological properties. One of these modifications is N-terminal pyroglutamate (pE) formation. Enzymatic glutaminyl cyclase (QC) activity catalyzes cyclization of truncated Aβ(3-x), generating pE3-Aβ. Compared to unmodified Aβ, pE3-Aβ is more hydrophobic and neurotoxic. In addition, it accelerates aggregation of other Aβ species. To directly investigate pE3-Aβ formation and toxicity in vivo, transgenic (tg) ETNA (E at the truncated N-terminus of Aβ) mice expressing truncated human Aβ(3–42) were generated and comprehensively characterized. To further investigate the role of QC in pE3-Aβ formation in vivo, ETNA mice were intercrossed with tg mice overexpressing human QC (hQC) to generate double tg ETNA-hQC mice. RESULTS: Expression of truncated Aβ(3–42) was detected mainly in the lateral striatum of ETNA mice, leading to progressive accumulation of pE3-Aβ. This ultimately resulted in astrocytosis, loss of DARPP-32 immunoreactivity, and neuronal loss at the sites of pE3-Aβ formation. Neuropathology in ETNA mice was associated with behavioral alterations. In particular, hyperactivity and impaired acoustic sensorimotor gating were detected. Double tg ETNA-hQC mice showed similar Aβ levels and expression sites, while pE3-Aβ were significantly increased, entailing increased astrocytosis and neuronal loss. CONCLUSIONS: ETNA and ETNA-hQC mice represent novel mouse models for QC-mediated toxicity of truncated and pE-modified Aβ. Due to their significant striatal neurodegeneration these mice can also be used for analysis of striatal regulation of basal locomotor activity and sensorimotor gating, and possibly for DARPP-32-dependent neurophysiology and neuropathology. The spatio-temporal correlation of pE3-Aβ and neuropathology strongly argues for an important role of this Aβ species in neurodegenerative processes in these models. BioMed Central 2013-10-01 /pmc/articles/PMC3850634/ /pubmed/24083638 http://dx.doi.org/10.1186/1471-2202-14-108 Text en Copyright © 2013 Becker et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Becker, Andreas
Kohlmann, Stephanie
Alexandru, Anca
Jagla, Wolfgang
Canneva, Fabio
Bäuscher, Christoph
Cynis, Holger
Sedlmeier, Reinhard
Graubner, Sigrid
Schilling, Stephan
Demuth, Hans-Ulrich
von Hörsten, Stephan
Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
title Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
title_full Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
title_fullStr Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
title_full_unstemmed Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
title_short Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
title_sort glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850634/
https://www.ncbi.nlm.nih.gov/pubmed/24083638
http://dx.doi.org/10.1186/1471-2202-14-108
work_keys_str_mv AT beckerandreas glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT kohlmannstephanie glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT alexandruanca glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT jaglawolfgang glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT cannevafabio glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT bauscherchristoph glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT cynisholger glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT sedlmeierreinhard glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT graubnersigrid glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT schillingstephan glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT demuthhansulrich glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration
AT vonhorstenstephan glutaminylcyclasemediatedtoxicityofpyroglutamatebetaamyloidinducesstriatalneurodegeneration